Associated Papers
Pathological insights from amyotrophic lateral sclerosis animal models: comparisons, limitations, and challenges.
Zhu L et al.
Translational Neurodegeneration, 2023
Characterizing TDP-43307-319 Oligomeric Assembly: Mechanistic and Structural Implications Involved in the Etiology of Amyotrophic Lateral Sclerosis.
Laos V et al.
Acs Chemical Neuroscience, 2019
The debated toxic role of aggregated TDP-43 in amyotrophic lateral sclerosis: a resolution in sight?
Hergesheimer RC et al.
Brain : a Journal of Neurology, 2019
Overexpression of the essential Sis1 chaperone reduces TDP-43 effects on toxicity and proteolysis.
Park SK et al.
Plos Genetics, 2017
Rodent Models of Amyotrophic Lateral Sclerosis.
Philips T et al.
Current Protocols in Pharmacology, 2015
TDP-43 functions and pathogenic mechanisms implicated in TDP-43 proteinopathies.
Cohen TJ et al.
Trends in Molecular Medicine, 2011
Rodent models of TDP-43 proteinopathy: investigating the mechanisms of TDP-43-mediated neurodegeneration.
Gendron TF et al.
Journal of Molecular Neuroscience : Mn, 2011
The role of mutant TAR DNA-binding protein 43 in amyotrophic lateral sclerosis and frontotemporal lobar degeneration.
Janssens J et al.
Biochemical Society Transactions, 2011
Progressive motor weakness in transgenic mice expressing human TDP-43.
Stallings NR et al.
Neurobiology of Disease, 2010
Pathogenic TARDBP mutations in amyotrophic lateral sclerosis and frontotemporal dementia: disease-associated pathways.
Barmada SJ et al.
Reviews in the Neurosciences, 2010
Select a paper to view details